To evaluate the responsiveness of RA CD4 + T cells to IL - 10, purified PB CD4 + T cells from three patients with active RA and from three healthy controls were stimulated by immobilized anti - CD3 antibody and anti - CD28 antibody with or without diluted concentrations of IL - 10 for 36 hours, and IFN - gamma production was measured by ELISA.	"CD4	37	40	Protein"	"IL - 10	54	61	Protein"	"CD4	75	78	Protein"	"CD3	194	197	Protein"	"CD28	218	222	Protein"	"IL - 10	274	281	Protein"	"IFN - gamma	300	311	Protein"	"[{""token"": ""CD4"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 274, ""end_span"": 281, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 300, ""end_span"": 311, ""type"": ""Protein""}]"
Serum IL - 6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4 + T cells, and exogenous IL - 6 induces the resistance to IL - 10 inhibition of IFN - gamma production.	"IL - 6	6	12	Protein"	"STAT3	38	43	Protein"	"STAT1	52	57	Protein"	"CD4	84	87	Protein"	"IL - 6	113	119	Protein"	"IL - 10	146	153	Protein"	"IFN - gamma	168	179	Protein"	"[{""token"": ""IL - 6"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""STAT3"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 168, ""end_span"": 179, ""type"": ""Protein""}]"
However, a series of studies demonstrated paucity of T cell - derived cytokines such as IL - 2 and interferon - gamma in the joints of RA, whereas macrophage and fibroblast cytokines including IL - 1, IL - 6, IL - 15, IL - 18 and TNF - alpha were abundant in rheumatoid synovium.	"IL - 2	88	94	Protein"	"interferon - gamma	99	117	Protein"	"IL - 1	193	199	Protein"	"IL - 6	201	207	Protein"	"IL - 15	209	216	Protein"	"IL - 18	218	225	Protein"	"TNF - alpha	230	241	Protein"	"[{""token"": ""IL - 2"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 99, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""IL - 1"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 201, ""end_span"": 207, ""type"": ""Protein""}, {""token"": ""IL - 15"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Protein""}, {""token"": ""IL - 18"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 230, ""end_span"": 241, ""type"": ""Protein""}]"
We detected an increase in IL - 17 level after stimulation with IL - 15 ( 10 ng / ml), whereas with IL - 1beta ( 10 ng / ml), TNF - alpha ( 10 ng / ml), IL - 18 ( 10 ng / ml) or TGF - beta ( 10 ng / ml) the levels in IL - 17 were unchanged ( Fig. 2a).	"IL - 17	27	34	Protein"	"IL - 15	64	71	Protein"	"IL - 1beta	100	110	Protein"	"TNF - alpha	126	137	Protein"	"IL - 18	153	160	Protein"	"TGF - beta	178	188	Protein"	"IL - 17	217	224	Protein"	"[{""token"": ""IL - 17"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""IL - 15"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""IL - 18"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Protein""}, {""token"": ""IL - 17"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Protein""}]"
Binding activities of NFkappaB, NFIL - 6 and NFAT from human PBMC to the TNFalpha, IL - 6 and IFNgamma promoters following an in vitro stimulation ( 1 h) with LPS, TSST - 1, GP, GP + LPS and GP + TSST - 1	"NFIL - 6	32	40	Protein"	"NFAT	45	49	Protein"	"TNFalpha	73	81	Protein"	"IL - 6	83	89	Protein"	"IFNgamma	94	102	Protein"	"TSST - 1	164	172	Protein"	"TSST - 1	196	204	Protein"	"[{""token"": ""NFIL - 6"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""NFAT"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""TNFalpha"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""TSST - 1"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Protein""}, {""token"": ""TSST - 1"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Protein""}]"
Our data indicated that GP leads to production of IL - 1RA primarily via induction of NFATP2 / 3 and NFIL - 6 DNA binding, which might be due to differences in the binding motif or the composition of the activated transcription factors ( NFAT) between the IFNgamma, IL - 6 and IL - 1RA promoter.	"NFATP2	86	92	Protein"	"3	95	96	Protein"	"NFIL - 6	101	109	Protein"	"NFAT	238	242	Protein"	"IFNgamma	256	264	Protein"	"IL - 6	266	272	Protein"	"IL - 1RA	277	285	Protein"	"[{""token"": ""NFATP2"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 95, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""NFIL - 6"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""NFAT"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 256, ""end_span"": 264, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 266, ""end_span"": 272, ""type"": ""Protein""}, {""token"": ""IL - 1RA"", ""start_span"": 277, ""end_span"": 285, ""type"": ""Protein""}]"
IFNgamma, TNFalpha, IL - 1 and IL - 6 were determined using an ELISA from Bender Systems ( Vienna, Austria), IL - 1RA and IL - 8 by an ELISA from R & D Systems ( Wiesbaden - Nordenstadt, Germany), and TGFbeta 1 using an ELISA as previously described [ 57].	"IFNgamma	0	8	Protein"	"TNFalpha	10	18	Protein"	"IL - 1	20	26	Protein"	"IL - 6	31	37	Protein"	"IL - 1RA	109	117	Protein"	"IL - 8	122	128	Protein"	"TGFbeta 1	201	210	Protein"	"[{""token"": ""IFNgamma"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Protein""}, {""token"": ""TNFalpha"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""IL - 1"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""IL - 1RA"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""TGFbeta 1"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Protein""}]"
Nuclear extracts were incubated with a 32P - labeled NFAT, NFkappaB, NFIL - 6 or NFkappaB - IL - 8 oligonucleotide probe corresponding to the IFNgamma, TNFalpha, IL - 6 and IL - 8 gene promoters ( Table 1).	"NFAT	53	57	Protein"	"NFIL - 6	69	77	Protein"	"IL - 8	92	98	Protein"	"IFNgamma	142	150	Protein"	"TNFalpha	152	160	Protein"	"IL - 6	162	168	Protein"	"IL - 8	173	179	Protein"	"[{""token"": ""NFAT"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""NFIL - 6"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Protein""}, {""token"": ""TNFalpha"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Protein""}]"
The IKK complex is comprised of the two catalytic subunits IKK1 and IKK2 ( also known as IKKalpha and IKKbeta) and the regulatory subunit NF - kappaB essential modulator ( NEMO - also known as IKKgamma) ( Figure 1).	"IKK1	59	63	Protein"	"IKK2	68	72	Protein"	"IKKalpha	89	97	Protein"	"IKKbeta	102	109	Protein"	"NF - kappaB essential modulator	138	169	Protein"	"NEMO	172	176	Protein"	"IKKgamma	193	201	Protein"	"[{""token"": ""IKK1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""IKK2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""IKKalpha"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""IKKbeta"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""NF - kappaB essential modulator"", ""start_span"": 138, ""end_span"": 169, ""type"": ""Protein""}, {""token"": ""NEMO"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Protein""}, {""token"": ""IKKgamma"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Protein""}]"
TNF stimulation results in the recruitment of TNF receptor - 1 - associated death domain ( TRADD) protein and of receptor interacting protein 1 ( RIP1), which function as adaptor proteins for the E3 ubiquitin ligases TNF receptor - associated factor ( TRAF) 2 and TRAF5, which in turn bind the E3 ubiquitin ligases cellular inhibitor of apoptosis ( cIAP) 1 and cIAP2 ( Figure 1).	"TNF	0	3	Protein"	"TNF receptor - 1 - associated death domain	46	88	Protein"	"TRADD	91	96	Protein"	"receptor interacting protein 1	113	143	Protein"	"RIP1	146	150	Protein"	"TRAF5	264	269	Protein"	"cIAP2	361	366	Protein"	"[{""token"": ""TNF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""TNF receptor - 1 - associated death domain"", ""start_span"": 46, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""TRADD"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""receptor interacting protein 1"", ""start_span"": 113, ""end_span"": 143, ""type"": ""Protein""}, {""token"": ""RIP1"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Protein""}, {""token"": ""TRAF5"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Protein""}, {""token"": ""cIAP2"", ""start_span"": 361, ""end_span"": 366, ""type"": ""Protein""}]"
Recently, the disruption of interactions between E2 ubiquitin conjugating enzymes ( Ubc13 and Ubc5hc) and E3 ubiquitin ligases ( TRAF6, TRAF2 and cIAP1 / 2) were described as another important mechanism used by A20 to downregulate NF - kappaB signalling [ 42].	"Ubc13	84	89	Protein"	"Ubc5hc	94	100	Protein"	"TRAF6	129	134	Protein"	"TRAF2	136	141	Protein"	"cIAP1	146	151	Protein"	"2	154	155	Protein"	"A20	211	214	Protein"	"[{""token"": ""Ubc13"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""Ubc5hc"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""TRAF6"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""cIAP1"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 154, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""A20"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Protein""}]"
A20 expression in synovial tissue was associated with inhibition of NF - kappaB activity and decreased levels of TNF, IL - 1beta, IL - 6, soluble RANKL, monocyte chemo - attractant protein 1, and IL - 17, suggesting that A20 induces a protective effect in collagen - induced arthritis mice through suppression of NF - kappaB activation and NF - kappaB - dependent gene expression [ 51].	"A20	0	3	Protein"	"TNF	113	116	Protein"	"IL - 1beta	118	128	Protein"	"IL - 6	130	136	Protein"	"RANKL	146	151	Protein"	"monocyte chemo - attractant protein 1	153	190	Protein"	"A20	221	224	Protein"	"[{""token"": ""A20"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""TNF"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 118, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Protein""}, {""token"": ""RANKL"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""monocyte chemo - attractant protein 1"", ""start_span"": 153, ""end_span"": 190, ""type"": ""Protein""}, {""token"": ""A20"", ""start_span"": 221, ""end_span"": 224, ""type"": ""Protein""}]"
Single - immunoglobulin IL - 1 receptor - related ( SIGIRR) protein, also known as TIR - 8, is a member of the TLR / IL - 1R family that has been extensively characterised as an inhibitor of IL - 1R and TLR signalling, probably through direct interaction with these receptors, MyD88, IRAK1 or TRAF6 [ 67] ( Figure 1).	"Single - immunoglobulin IL - 1 receptor - related	0	49	Protein"	"SIGIRR	52	58	Protein"	"TIR - 8	83	90	Protein"	"IL - 1R	117	124	Protein"	"MyD88	277	282	Protein"	"IRAK1	284	289	Protein"	"TRAF6	293	298	Protein"	"[{""token"": ""Single - immunoglobulin IL - 1 receptor - related"", ""start_span"": 0, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""SIGIRR"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""TIR - 8"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""IL - 1R"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""MyD88"", ""start_span"": 277, ""end_span"": 282, ""type"": ""Protein""}, {""token"": ""IRAK1"", ""start_span"": 284, ""end_span"": 289, ""type"": ""Protein""}, {""token"": ""TRAF6"", ""start_span"": 293, ""end_span"": 298, ""type"": ""Protein""}]"
In unstimulated cells NIK forms a cytosolic complex with the ubiquitin ligases TRAF2, TRAF3 and cIAP1 / 2, which facilitates the K48 - linked polyubiquitination and proteasomal degradation of NIK, keeping NIK levels low.	"NIK	22	25	Protein"	"TRAF2	79	84	Protein"	"TRAF3	86	91	Protein"	"cIAP1	96	101	Protein"	"2	104	105	Protein"	"NIK	192	195	Protein"	"NIK	205	208	Protein"	"[{""token"": ""NIK"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""TRAF2"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Protein""}, {""token"": ""TRAF3"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Protein""}, {""token"": ""cIAP1"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 104, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""NIK"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Protein""}, {""token"": ""NIK"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Protein""}]"
Cells were stained with monoclonal antibodies directed against MHC - II ( I - A / I - E) FITC ( M5 / 114. 15. 2), CD11c PerCP - Cy5. 5 ( N418), F4 / 80 APC ( BM8), CD62L PE ( MEL - 14), Granzyme B FITC ( NGZB) from eBiosciences and CD3 Molecular Complex Horizon v450 ( 17A2), Ly6C Horizon v450 ( AL - 21), Ly6G PE ( 1A8), CD11b APC - Cy7 ( M1 / 70), CD8alpha PerCP ( 53 - 6. 7), IFNgamma Alexa 647 ( XMG1. 2) and CD16 / 32 ( 2. 4G2) from BD Pharmingen.	"CD62L	164	169	Protein"	"Granzyme B	186	196	Protein"	"CD3	232	235	Protein"	"Ly6G	306	310	Protein"	"CD8alpha	350	358	Protein"	"IFNgamma	379	387	Protein"	"CD16	413	417	Protein"	"[{""token"": ""CD62L"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Protein""}, {""token"": ""Granzyme B"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Protein""}, {""token"": ""Ly6G"", ""start_span"": 306, ""end_span"": 310, ""type"": ""Protein""}, {""token"": ""CD8alpha"", ""start_span"": 350, ""end_span"": 358, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 379, ""end_span"": 387, ""type"": ""Protein""}, {""token"": ""CD16"", ""start_span"": 413, ""end_span"": 417, ""type"": ""Protein""}]"
TNF - alpha shows various effects on brain function depending on its local tissue concentration, the type of target cells, and especially the specific receptor subtype: TNF receptor I, or p55 receptor ( TNFp55R); and TNF receptor II, or p75 receptor ( TNFp75R) [ 19].	"TNF - alpha	0	11	Protein"	"TNF receptor I	169	183	Protein"	"p55 receptor	188	200	Protein"	"TNFp55R	203	210	Protein"	"TNF receptor II	217	232	Protein"	"p75 receptor	237	249	Protein"	"TNFp75R	252	259	Protein"	"[{""token"": ""TNF - alpha"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Protein""}, {""token"": ""TNF receptor I"", ""start_span"": 169, ""end_span"": 183, ""type"": ""Protein""}, {""token"": ""p55 receptor"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Protein""}, {""token"": ""TNFp55R"", ""start_span"": 203, ""end_span"": 210, ""type"": ""Protein""}, {""token"": ""TNF receptor II"", ""start_span"": 217, ""end_span"": 232, ""type"": ""Protein""}, {""token"": ""p75 receptor"", ""start_span"": 237, ""end_span"": 249, ""type"": ""Protein""}, {""token"": ""TNFp75R"", ""start_span"": 252, ""end_span"": 259, ""type"": ""Protein""}]"
To determine the specificity of these substitutions upon NFAT5 and NF - kappaB p50 / p65 binding to the LTR, we performed a quantitative DNase I footprinting analysis using the wild - type LTR or mutant LTRs in combination with increasing concentrations of recombinant NFAT5 or NF - kappaB p50 / p65 proteins.	"NFAT5	57	62	Protein"	"p50	79	82	Protein"	"p65	85	88	Protein"	"DNase I	137	144	Protein"	"NFAT5	269	274	Protein"	"p50	290	293	Protein"	"p65	296	299	Protein"	"[{""token"": ""NFAT5"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""DNase I"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Protein""}, {""token"": ""NFAT5"", ""start_span"": 269, ""end_span"": 274, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 296, ""end_span"": 299, ""type"": ""Protein""}]"
Quantitative DNaseI footprinting analysis is shown of nucleotides - 262 to + 4 from HIV - 1Lai / Bal - env - WT, HIV - 1Lai / Bal - env - kappaB I - Mut, HIV - 1Lai / Bal - env - kappaB II - Mut, and HIV - 1Lai / Bal - env - kappaB I + II - Mut and increasing concentrations of recombinant NF - kappaB ( p50 / p65) ( 25 ng, 100 ng, and 500 ng).	"DNaseI	13	19	Protein"	"env	103	106	Protein"	"env	132	135	Protein"	"env	173	176	Protein"	"env	219	222	Protein"	"p50	304	307	Protein"	"p65	310	313	Protein"	"[{""token"": ""DNaseI"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Protein""}, {""token"": ""env"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""env"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""env"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Protein""}, {""token"": ""env"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 304, ""end_span"": 307, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 310, ""end_span"": 313, ""type"": ""Protein""}]"
Expression of the C / EBP - beta phospho - acceptor mutant, C / EBPbetaT217A, in Cebpb - / - MEFs did not significantly increase SerpinB2 promoter activity above that of wild - type C / EBP - beta ( Fig. 8C, right); confirming that phosphorylation of C / EBP - beta at T217 is not a major factor in the regulation of SerpinB2 promoter activity in response to LPS.	"C / EBP - beta phospho - acceptor mutant	18	58	Protein"	"C / EBPbetaT217A	60	76	Protein"	"Cebpb	81	86	Protein"	"SerpinB2	129	137	Protein"	"C / EBP - beta	182	196	Protein"	"C / EBP - beta	251	265	Protein"	"SerpinB2	317	325	Protein"	"[{""token"": ""C / EBP - beta phospho - acceptor mutant"", ""start_span"": 18, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""C / EBPbetaT217A"", ""start_span"": 60, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""Cebpb"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""SerpinB2"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""C / EBP - beta"", ""start_span"": 182, ""end_span"": 196, ""type"": ""Protein""}, {""token"": ""C / EBP - beta"", ""start_span"": 251, ""end_span"": 265, ""type"": ""Protein""}, {""token"": ""SerpinB2"", ""start_span"": 317, ""end_span"": 325, ""type"": ""Protein""}]"
